STOCK TITAN
  1. Home
  2. Sec-filings
  3. TCRT
  4. [8-K] Alaunos Therapeutics, Inc. Reports Material Event

[8-K] Alaunos Therapeutics, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock TCRT logo
Alaunos Therapeutics, Inc

NASDAQ:TCRT

TCRT Rankings

#6397 Ranked by Market Cap
N/A Ranked by Dividends
#168 Top Gainer

TCRT Latest News

Jun 23, 2025
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
Nov 14, 2023
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Aug 14, 2023
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
Jun 29, 2023
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies
May 25, 2023
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting

TCRT Latest SEC Filings

Oct 1, 2025
[S-3/A] Alaunos Therapeutics, Inc. Amended Shelf Registration Statement
Sep 8, 2025
[S-3/A] Alaunos Therapeutics, Inc. Amended Shelf Registration Statement
Sep 8, 2025
[S-3/A] Alaunos Therapeutics, Inc. Amended Shelf Registration Statement
Sep 8, 2025
[S-3/A] Alaunos Therapeutics, Inc. Amended Shelf Registration Statement
Sep 5, 2025
[SCHEDULE 13D/A] Alaunos Therapeutics, Inc. SEC Filing

TCRT Stock Data

6.62M
1.97M
10.6%
4.77%
4.56%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON